PE-Cy7 Mouse Anti-Human CD105 Antibody (S-837-10)

產(chǎn)品型號：S0B1813

更新時(shí)間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問量：133

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

流式抗體封閉：如何有效避免實(shí)驗(yàn)中的假陽性結(jié)果？

成纖維細(xì)胞生長因子受體2b抗體：從基礎(chǔ)研究到臨床轉(zhuǎn)化的前沿探索

腸道黏蛋白 MUC2：從黏液屏障到疾病開關(guān)的雙重身份解碼

TDP-43與漸凍癥：守護(hù)or背叛？

產(chǎn)品介紹

Endoglin （ENG） is a type I membrane glycoprotein located on cell surfaces and is part of the TGF beta receptor complex. It is also commonly referred to as CD105, END, FLJ41744, HHT1, ORW and ORW1. Endoglin has been found to be an auxiliary receptor for the TGF-beta receptor complex. It thus is involved in modulating a response to the binding of TGF-beta1, TGF-beta3, activin-A, BMP-2, BMP-7 and BMP-9. Beside TGF-beta signaling endoglin may have other functions. It has been postulated that endoglin is involved in the cytoskeletal organization affecting cell morphology and migration. Endoglin has a role in the development of the cardiovascular system and in vascular remodeling. Its expression is regulated during heart development. In humans endoglin may be involved in the autosomal dominant disorder known as hereditary hemorrhagic telangiectasia （HHT） type 1.

上一個(gè)：S0B1814PE-Cy7 Rat Anti-Mouse Ly-6C Antibody (S-R523)